Depth of response (CR/VGPR, MRD-) links to better outcomes, while biochemical progression predicts end-organ damage. Higher MHC-I on tumors and greater GZMB+ T cells in clonally expanded CD8 ...

Northwell Health has appointed David J. Chung, MD, PhD, a prominent oncologist-investigator, as director of clinical research at the Northwell Health Cancer Institute. In this newly created role, Dr.

The overall response rate was 43.3% in the 1.5 mg/kg dose group and 42.9% in the 3.0 mg/kg dose group. Modakafusp alfa “warrants continued exploration” as a treatment for patients with ...